Literature DB >> 26616342

In quest for method of insulin resistance assessment in everyday clinical practice-Insulin resistance indices.

Konrad Szosland1, Andrzej Lewiński2.   

Abstract

UNLABELLED: Insulin resistance (IR) a state of decreased sensitivity of target tissues to insulin is suspected usually in obese so can be overlooked in normal weight subjects thus it is important to find optimal method of IR assessment in clinical practice.
METHODS: HOMA, HOMA2, QUICKI, Matsuda index were calculated using data obtained from medical history of 130 female subjects - patients of the Department of Endocrinology and Metabolic Diseases, in whom oral glucose tolerance test (OGTT) with parallel insulin concentrations assessment was performed.
RESULTS: IR correlated positively with body mass index (BMI) in the entire study group, regardless which of four analyzed IR indices was used. Insulin resistance occurred in the obese as well as in normal weight and underweight subjects. The incidences of IR in the study group varied, depending upon chosen method and adopted cut-off values.
CONCLUSIONS: The need for quantitative assessment of IR in clinical practice is apparent. Proper selection of the best method of IR assessment remains a problem. HOMA appears the method of first choice for clinical use. There is an urgent need to establish universal or, at least, national standard cut-off values for IR, to introduce IR assessment in clinical practice.
Copyright © 2015 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body mass index; HOMA; Insulin resistance; Matsuda Index; QUICKI

Mesh:

Substances:

Year:  2015        PMID: 26616342     DOI: 10.1016/j.dsx.2015.10.007

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  7 in total

Review 1.  Insulin resistance in the course of acne - literature review.

Authors:  Anna Sadowska-Przytocka; Michalina Gruszczyńska; Anna Ostałowska; Patrycja Antosik; Magdalena Czarnecka-Operacz; Zygmunt Adamski; Katarzyna Łącka
Journal:  Postepy Dermatol Alergol       Date:  2021-06-18       Impact factor: 1.664

2.  Limitations of insulin resistance assessment in polycystic ovary syndrome.

Authors:  Krzysztof C Lewandowski; Justyna Płusajska; Wojciech Horzelski; Ewa Bieniek; Andrzej Lewiński
Journal:  Endocr Connect       Date:  2018-02-07       Impact factor: 3.335

3.  How much insulin resistance in polycystic ovary syndrome? Comparison of HOMA-IR and insulin resistance (Belfiore) index models.

Authors:  Krzysztof C Lewandowski; Elżbieta Skowrońska-Jóźwiak; Katarzyna Łukasiak; Katarzyna Gałuszko; Aleksandra Dukowicz; Magdalena Cedro; Andrzej Lewiński
Journal:  Arch Med Sci       Date:  2019-01-30       Impact factor: 3.318

4.  Associations of Chronic Inflammation, Insulin Resistance, and Severe Obesity With Mortality, Myocardial Infarction, Cancer, and Chronic Pulmonary Disease.

Authors:  Natasha Wiebe; Peter Stenvinkel; Marcello Tonelli
Journal:  JAMA Netw Open       Date:  2019-08-02

5.  Effect of a Low-Carbohydrate High-Fat Diet and a Single Bout of Exercise on Glucose Tolerance, Lipid Profile and Endothelial Function in Normal Weight Young Healthy Females.

Authors:  Thorhildur Ditta Valsdottir; Christine Henriksen; Nancy Odden; Birgitte Nellemann; Per B Jeppesen; Jonny Hisdal; Ane C Westerberg; Jørgen Jensen
Journal:  Front Physiol       Date:  2019-12-19       Impact factor: 4.566

Review 6.  Effects of Polyphenols on Insulin Resistance.

Authors:  Gary Williamson; Katherine Sheedy
Journal:  Nutrients       Date:  2020-10-14       Impact factor: 5.717

7.  Acanthosis nigricans in the knuckles: An early, accessible, straightforward, and sensitive clinical tool to predict insulin resistance.

Authors:  Gloria González-Saldivar; René Rodríguez-Gutiérrez; Andrés Marcelo Treviño-Alvarez; Minerva Gómez-Flores; Juan Montes-Villarreal; Neri Alejandro Álvarez-Villalobos; Anasofía Elizondo-Plazas; Alejandro Salcido-Montenegro; Jorge Ocampo-Candiani; José Gerardo González-González
Journal:  Dermatoendocrinol       Date:  2018-05-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.